JAK2 and acquired polycythemia vera: Unfortunately, none of these features is specific for PV [40], since they all rely on the presence of activated JAK2, and are also affected by the JAK2 V617F mutation quantitative allele burden (MAB, [also known as the variant allele fraction or VAF]) and disease duration.